Daily BriefsECM

Daily Brief ECM: Bilibili Follow-On Offering – Seems Opportunistic and more

In today’s briefing:

  • Bilibili Follow-On Offering – Seems Opportunistic
  • China Education Group Placement – Recent Momentum Has Been Strong but past Deals Were Mixed
  • Lotte Chemical Offering: Schedule Clarifications & Trading Considerations
  • TEMC: Reduces IPO Price & Bookbuilding Results
  • Aequitas 2022 IPOs and Placements Performance Review – From the Busiest Year to the Slowest Year
  • Bilibili Follow-On Offering: Limited Upside
  • Honasa Consumer Pre-IPO Tearsheet

Bilibili Follow-On Offering – Seems Opportunistic

By Sumeet Singh

  • Bilibili Inc (BILI US)  aims to raise around US$400m via a follow-on ADS offering.
  • The company plans to use most of the proceeds to redeem its 2026 notes.
  • In this note, we will talk about the deal dynamics and  run the deal through our ECM framework.

China Education Group Placement – Recent Momentum Has Been Strong but past Deals Were Mixed

By Sumeet Singh

  • China Education Group (839 HK) is looking to raise up to US$209m in its top-up placement. 
  • This will be the fourth placement by the group since its listing in 2017, we have earlier looked at the past three placements as well.
  • In this note, we will look  at the deal dynamics and run the deal through our ECM framework.

Lotte Chemical Offering: Schedule Clarifications & Trading Considerations

By Sanghyun Park

  • The subscription starts on January 19, so the pricing is January 16, three trading days earlier. The shorting restriction runs until January 16, which means the 16th is inclusive.
  • There was no arb spread opening during the last four trading days of the subscription rights trade period. Nonetheless, this event had some impact on Lotte Chemical’s futures trading.
  • Considering this, the trade that can be considered at this point would be unhedged shorting. We target potential inflow to adjust the second issuing price downwardly and post-listing overhangs.

TEMC: Reduces IPO Price & Bookbuilding Results

By Douglas Kim

  • TEMC announced its IPO price of 28,000 won, which was lower than the IPO price range of 32,000 won to 38,000 won.
  • There were 560 institutions that participated in the IPO bookbuilding survey and the demand ratio was 31.3 to 1.
  • Our base valuation is 38,363 won per share, representing a 37% upside to the IPO price of 28,000 won. The reduced IPO price has made the IPO more attractive.

Aequitas 2022 IPOs and Placements Performance Review – From the Busiest Year to the Slowest Year

By Sumeet Singh

  • 2022 marked our seventh year covering Equity Capital Markets (ECM) in Asia Pacific. 2022 was rather quiet ending with us covering one of the lowest number of IPOs and placements.
  • We ended 2022 with an accuracy rate of 74.6% across 55 IPOs that we covered and 70.5% across 78 placements. 
  • For those not familiar with our coverage, we aim to cover all IPOs and placements with a minimum deal size of US$100m across Asia-Pacific, including China ADRs.

Bilibili Follow-On Offering: Limited Upside

By Shifara Samsudeen, ACMA, CGMA

  • Bilibili announced a follow-on equity offering of 15.34m ADS priced at $26.65 per ADS partially in exchange for convertible senior notes due 2026 (US$384.8m) and to replenish its cash reserves.
  • Each ADS represents one ordinary share and new equity offering of 15.34m shares will account for approx. 3.7% of the company’s extended share capital post follow-on offering.
  • Bilibili Inc (BILI US) ADS dropped 5.76% following the announcement of the follow-on offering and we believe there is limited upside.

Honasa Consumer Pre-IPO Tearsheet

By Ethan Aw

  • Honasa Consumer (1652951D IN) is looking to raise about US$350m in its upcoming India IPO. The deal will be run by Kotak, Citibank, JM Financial and JP Morgan.
  • Honasa Consumer is the largest digital-first beauty and personal care (BPC) company in India in terms of revenue for FY22 (Year ended 31st Mar 2022) according to RedSeer. 
  • Honasa Consumer’s product portfolio includes products in the baby care, face care, body care, hair care, color cosmetics and fragrances segments. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars